MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,012,631 | -30.1% | 1,464,015 | 0.0% | 0.45% | -16.5% |
| Q2 2023 | $10,028,502 | -12.1% | 1,464,015 | 0.0% | 0.54% | -14.7% |
| Q1 2023 | $11,404,677 | +2.4% | 1,464,015 | 0.0% | 0.63% | -2.3% |
| Q4 2022 | $11,141,154 | -6.9% | 1,464,015 | 0.0% | 0.65% | +5.9% |
| Q3 2022 | $11,961,000 | -15.5% | 1,464,015 | 0.0% | 0.61% | -20.4% |
| Q2 2022 | $14,157,000 | -31.0% | 1,464,015 | 0.0% | 0.77% | +15.3% |
| Q1 2022 | $20,525,000 | -31.3% | 1,464,015 | 0.0% | 0.67% | -7.8% |
| Q4 2021 | $29,895,000 | -8.3% | 1,464,015 | 0.0% | 0.72% | -6.7% |
| Q3 2021 | $32,618,000 | -1.9% | 1,464,015 | 0.0% | 0.77% | +14.3% |
| Q2 2021 | $33,233,000 | – | 1,464,015 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |